Clinical analysis of operation combined chemotherapy for stage IIIa non-small cell lung cancer / 中华外科杂志
Chinese Journal of Surgery
;
(12): 1450-1452, 2005.
Article
in Chinese
| WPRIM
| ID: wpr-306088
ABSTRACT
<p><b>OBJECTIVE</b>To study the therapeutic result of operation combined chemotherapy for stage IIIa non-small cell lung cancer.</p><p><b>METHODS</b>From January 2000 to December 2003, the data of 83 cases with stage IIIa non-small cell lung cancer undergoing operation combined chemotherapy and 33 cases with stage IIIa non-small cell lung cancer undergoing non-operative therapy were retrospectively analyzed. The median survival time and the 1-, 2-, 3- year survival rates of the two groups were compared by the Kaplan-Meier method.</p><p><b>RESULTS</b>The median survival time of the operation group was 20.3 months, and the 1-, 2-, 3- year survival rates were 85%, 70%, and 35% respectively. The median survival time of the non-operation group was 14.5 months and the 1-, 2-, 3- year survival rates were 75%, 33%, and 15% respectively.</p><p><b>CONCLUSION</b>The therapeutic result of the operation combined chemotherapy for the stage IIIa non-small cell lung cancer is better than that of the non-operative therapy obviously.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Pneumonectomy
/
General Surgery
/
Survival Rate
/
Retrospective Studies
/
Mortality
/
Treatment Outcome
/
Combined Modality Therapy
/
Carcinoma, Non-Small-Cell Lung
/
Drug Therapy
Type of study:
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Chinese Journal of Surgery
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS